Current Investments

Dr. Arnold L. Oronsky has been with InterWest Partners since 1994. As a Ph.D. in immunology and senior lecturer at the Department of Medicine at Johns Hopkins Medical School, Dr. Oronsky brings a deep understanding of oncology, infectious diseases, cardiovascular, central nervous system, metabolic diseases and vaccines to finding and investing in successful life sciences companies.

Currently, Dr. Oronsky serves as a member of the board of directors for the following publicly held life science companies: Anesiva, Aspreva Pharmaceuticals, Dynavax Technologies and Metabasis Therapeutics. In addition, Dr. Oronsky serves on the board of directors for several privately held companies, including AkaRx, Applied Genetic Technologies Corporation (AGTC), Diatos S.A., Kanisa Pharmaceuticals, and MacroGenics.

Prior to joining InterWest, Dr. Oronsky was the vice president for discovery research for the Lederle Laboratories division of American Cyanamid Company where he directed the research for new drugs.

Dr. Oronsky holds a Ph.D. in immunology from Columbia University and has published more than 125 articles in scientific journals.

A Word from Arnie

"I came to InterWest after leading a large research organization at Lederle Laboratories. It's one thing to understand the science and its potential, but quite a different challenge to turn that science into a profitable company that meets real market and health care needs. Through my years at InterWest, I have found that my greatest challenge and greatest achievement is to marry outstanding science to outstanding management in order to build a durable, successful company."